Contributions of hyperhomocysteinemia to atherosclerosis: Causal relationship and potential mechanisms.
about
Homocysteine-lowering interventions for preventing cardiovascular eventsHomocysteine-lowering interventions for preventing cardiovascular eventsHomocysteine lowering interventions for preventing cardiovascular eventsVitamin B12 in health and diseaseUnderstanding the pathogenesis of abdominal aortic aneurysmsHyperhomocysteinaemia in rats is associated with erectile dysfunction by impairing endothelial nitric oxide synthase activity.Endoplasmic reticulum stress and atherosclerosisAssociation of homocysteine levels with blood lead levels and micronutrients in the US general populationGlucoraphanin does not reduce plasma homocysteine in rats with sufficient Se supply via the induction of liver ARE-regulated glutathione biosynthesis enzymes.Study of molecular targets influencing homocysteine and cholesterol metabolism in growing rats by manipulation of dietary selenium and methionine concentrations.Genetic analysis of six SNPs in candidate genes associated with high cross-race risk of development of thoracic aortic aneurysms and dissections in Chinese Han populationAssociation of optimism and pessimism with inflammation and hemostasis in the Multi-Ethnic Study of Atherosclerosis (MESA)Serum adiponectin, leptin, C-peptide, homocysteine, and colorectal adenoma recurrence in the Polyp Prevention Trial.A panel of biomarkers is associated with increased risk of the presence and progression of atherosclerosis in women with systemic lupus erythematosus.Cardiovascular disease markers in women with polycystic ovary syndrome with emphasis on asymmetric dimethylarginine and homocysteine.The role of endoplasmic reticulum stress in the progression of atherosclerosis.Effect of chronic kidney disease on the expression of thiamin and folic acid transportersPlasma levels of homocysteine and cysteine increased in pediatric NAFLD and strongly correlated with severity of liver damage.High fat diet-induced non alcoholic fatty liver disease in rats is associated with hyperhomocysteinemia caused by down regulation of the transsulphuration pathway.Sensitivity of staurosporine-induced differentiated RGC-5 cells to homocysteineAcute administration of L-DOPA induces changes in methylation metabolites, reduced protein phosphatase 2A methylation, and hyperphosphorylation of Tau protein in mouse brain.Effects of rosuvastatin on the production and activation of matrix metalloproteinase-2 and migration of cultured rat vascular smooth muscle cells induced by homocysteine.The C677T variant in MTHFR modulates associations between blood-based and cerebrospinal fluid biomarkers of neurodegeneration.Sex Difference in the Association between Serum Homocysteine Level and Non-Alcoholic Fatty Liver Disease.Pathophysiology of thoracic aortic aneurysm (TAA): is it not one uniform aorta? Role of embryologic originVitamin B12 status in women of childbearing age in the UK and its relationship with national nutrient intake guidelines: results from two National Diet and Nutrition Surveys.Association between Stable Coronary Artery Disease and In Vivo Thrombin GenerationIntestinal metabolism of sulfur amino acids.Endoplasmic reticulum stress and lipid dysregulation.Homocysteine as a risk factor for atherosclerosis: is its conversion to s-adenosyl-L-homocysteine the key to deregulated lipid metabolism?Mitochondrial mitophagic mechanisms of myocardial matrix metabolism and remodelling.Folate, homocysteine and the cardiac neural crest.The UPR in atherosclerosisRole of endoplasmic reticulum stress in atherosclerosis and diabetic macrovascular complications.Safety considerations with fenofibrate/simvastatin combination.Rheumatoid Arthritis Pharmacotherapies: Do They Have Anti-Atherosclerotic Activity?High-methionine diets accelerate atherosclerosis by HHcy-mediated FABP4 gene demethylation pathway via DNMT1 in ApoE(-/-) mice.Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.Methionine-induced hyperhomocysteinemia impairs the antioxidant ability of high-density lipoproteins without reducing in vivo macrophage-specific reverse cholesterol transport.Homocysteine induces COX-2 expression in macrophages through ROS generated by NMDA receptor-calcium signaling pathways.
P2860
Q24186605-2615BF2C-768B-43A2-9ED5-A7A44BEAF61EQ24201783-38B260B8-FDBF-4D96-BF38-2AFA342E70B1Q24239981-2C4C0473-45A7-4358-81D2-0270E47A5D13Q24610264-6FB11CDB-130D-4852-B5F4-A8DC6F283CD8Q26797277-982357BA-1C25-4F41-B27A-0E2657090652Q27312470-AE6A9FC3-76A6-492B-A022-F88E29D02A5DQ28279152-BAE0198B-A112-4901-8B23-F6A132D28D8FQ28391704-3785C4B1-8297-4D77-ADF3-8309E17CABE5Q30318303-8A91EC1F-A1B6-4988-87BE-B49ABF55D76EQ30318724-3631B5D1-1896-4F23-B8A5-5B5C6EC1BBFCQ33577610-ECA8AF71-E315-4E78-8AC1-FADE17B94541Q33743835-E1A6EA7E-78CA-43C2-86CA-066EACCF6413Q33903099-10B89B99-AD89-4D1D-973C-442FF8D5EAF7Q33931813-01291093-B409-4589-A677-43651FCE5E98Q34099243-1546A784-FF25-43DC-A033-0E08C76B4884Q34141006-D05E98FC-7D35-4901-93A7-FD2E6A35D26DQ34154431-EF6F2F3C-3B36-4725-B395-053B8CBDD1F9Q34685694-723D743C-CBBE-40A1-BD22-E76B6F5A91F7Q34989210-2C8CC770-4A84-4C70-A738-4CDCC28B5BCEQ35513957-9570B8D4-2E6F-49D3-8956-B86B9815BD6EQ36174698-B9CE79E7-E204-45E5-8A59-EE36F3EE836BQ37076595-85017E9F-AB18-4E20-A39A-AB69150C4282Q37077593-5EB380D9-823B-482D-9A3A-81746B74847BQ37128080-B4FF2431-6385-4AF3-88F1-7D80225A5C6FQ37138901-E6B37395-9DE0-4BD3-AF39-834191301D44Q37177612-6460D05B-1514-4891-A24E-34ED186A13EBQ37202070-8F17ACA5-4B50-4829-94CD-D235A464E017Q37616232-9A25A218-9C6B-4BE1-A974-A6F1F3FF5802Q37834712-E1C9D02A-F674-4B2D-807B-027566CC3565Q37916306-4EF9FE44-1862-45B0-B7DD-A6089FADBE24Q37969775-A5ECE116-EF5E-4DDF-A86C-926C15B7FEB8Q38075509-BC080956-3044-411B-9D2D-39959C53FCA1Q38095788-11941A10-3658-48D7-9A0B-B1C73A55FE71Q38233882-20BEE9E5-1ACB-4CB9-BA00-81C435358F48Q38541832-C76F24BE-5BB2-467D-905A-953BCEEFAD07Q38794852-F2ED4588-AF74-441F-9F04-8A84AB8A54CAQ38816765-62792A1D-9809-49C9-9B1A-711AFADC797CQ38879090-C2216B3B-52A9-4F57-9029-7259584D2D9AQ39141274-3C0E2454-7073-4DED-8813-CF937BA8A719Q39181777-71FFCFA4-AB8A-48C3-9628-F9274C44D00E
P2860
Contributions of hyperhomocysteinemia to atherosclerosis: Causal relationship and potential mechanisms.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Contributions of hyperhomocyst ...... ship and potential mechanisms.
@en
Contributions of hyperhomocyst ...... ship and potential mechanisms.
@nl
type
label
Contributions of hyperhomocyst ...... ship and potential mechanisms.
@en
Contributions of hyperhomocyst ...... ship and potential mechanisms.
@nl
prefLabel
Contributions of hyperhomocyst ...... ship and potential mechanisms.
@en
Contributions of hyperhomocyst ...... ship and potential mechanisms.
@nl
P2860
P356
P1433
P1476
Contributions of hyperhomocyst ...... ship and potential mechanisms.
@en
P2093
Richard C Austin
P2860
P304
P356
10.1002/BIOF.17
P577
2009-03-01T00:00:00Z